We partner with countries and work at the global level to assess supply and demand for health products and build markets that address the five A’s: affordability, availability, assured quality, appropriate design, and awareness.
A new initiative led by PATH in partnership with John Snow, Inc., the DMPA-SC Access Collaborative works with ministries of health and partners to strengthen scale-up and build a robust global market for DMPA-SC as an important addition to the full range of contraceptive options.
Family planning leaders can draw from an established base of evidence to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.
Several thousands of health workers around the world have been trained to safely provide DMPA-SC injections in clinics, community locations, and villages, and even to support women to self-inject.
Countries have to determine how to make the best use of limited resources. PATH uses health economics to inform countries' decisions about vaccines.
How PATH partnerships deliver fortified rice from field to fork in Myanmar.
For Africans with diabetes, medicines and supplies are often hard to access. We’re working to erase those barriers.